Furthermore, SIRT2 influences the metabolic profile of cancer cells by inducing the production of lactosylceramide through the upregulation of B4GALT5 beta-1,4-galactosyltransferase 5 (B4GALT5), which enhances the invasive potential of PCa cells. Here, SIRT2 is linked to cancer.